Your browser doesn't support javascript.
loading
Ladarixin, an inhibitor of the interleukin-8 receptors CXCR1 and CXCR2, in new-onset type 1 diabetes: A multicentre, randomized, double-blind, placebo-controlled trial.
Piemonti, Lorenzo; Keymeulen, Bart; Gillard, Pieter; Linn, Thomas; Bosi, Emanuele; Rose, Ludger; Pozzilli, Paolo; Giorgino, Francesco; Cossu, Efisio; Daffonchio, Luisa; Goisis, Giovanni; Ruffini, Pier Adelchi; Maurizi, Anna Rita; Mantelli, Flavio; Allegretti, Marcello.
Afiliación
  • Piemonti L; IRCCS Ospedale San Raffaele and Università Vita-Salute, Diabetes Research Institute, Milan, Italy.
  • Keymeulen B; The Belgian Diabetes Registry, Academic Hospital and Diabetes Research Centre, Vrije Universiteit Brussel, Brussels, Belgium.
  • Gillard P; Department of Endocrinology, University Hospitals Leuven-KU Leuven, Leuven, Belgium.
  • Linn T; Clinical Research Unit, Medical Clinic and Polyclinic III, Center of Internal Medicine, Justus Liebig University, Giessen, Germany.
  • Bosi E; IRCCS Ospedale San Raffaele and Università Vita-Salute, Diabetes Research Institute, Milan, Italy.
  • Rose L; Zentrum für Diabetes und Gefäßerkrankungen Münster, Munster, Germany.
  • Pozzilli P; Department of Endocrinology and Metabolic Diseases, University Campus Bio-Medico, Rome, Italy.
  • Giorgino F; Department of Emergency and Organ Transplantation, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy.
  • Cossu E; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Daffonchio L; Research and Development, Dompé farmaceutici S.p.A, Milan, Italy.
  • Goisis G; Research and Development, Dompé farmaceutici S.p.A, Milan, Italy.
  • Ruffini PA; Research and Development, Dompé farmaceutici S.p.A, Milan, Italy.
  • Maurizi AR; Research and Development, Dompé farmaceutici S.p.A, Milan, Italy.
  • Mantelli F; Research and Development, Dompé farmaceutici S.p.A, Milan, Italy.
  • Allegretti M; Research and Development, Dompé farmaceutici S.p.A, Milan, Italy.
Diabetes Obes Metab ; 24(9): 1840-1849, 2022 09.
Article en En | MEDLINE | ID: mdl-35589610
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido